INQOVI (decitabine and cedazuridine) 35mg/100mg tablets HCP InformationINQOVI (decitabine and cedazuridine) 35mg/100mg tablets Dosing Information
LONSURF ® (trifluridine and tipiracil) tablets Efficacy InformationLONSURF ® (trifluridine and tipiracil) tablets Dosing Information
Taiho Oncology Patient Access Support BrochureTaiho Oncology Copay Brochure
Taiho Oncology is a different kind of pharmaceutical company. We have deep roots and unmatched corporate agility that enable us to fulfill our purpose – making treatments for Oncology.
For almost two decades, Taiho Oncology has served as a clinical organization, where people are at the center of everything we do. Together, we work urgently to discover and develop treatments that address today’s unmet patient needs and apply the behind them.
As the field of Oncology treatment evolves, we evolve with it. Technology, dedicated investigators, and established facilities—these vast resources empower us. It’s our work; it’s our passion; it’s our legacy.
Developed by © Astex Pharmaceuticals, Inc. Marketed by © Taiho Oncology, Inc. INQOVI® is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Copyright © TAIHO ONCOLOGY, INC. 2020 All rights reserved.
© TAIHO ONCOLOGY, INC. All rights reserved. Lonsurf is a registered trademark of Taiho Pharmaceutical Co., Ltd used under license by Taiho Oncology, Inc.
